New Antibody for FGFR1

This page contains an archive of our research area specific eNewsletters. If you would like to be kept up to date on new products, promotions, and up and coming events, sign up to receive Novus eNews. Create a new account here, or if you already have an account, login and click on Profile.

Histone H3 is a key protein in the studies of epigenetics. The protein consists of a globular domain and a flexible N-terminal tail; the tail protrudes from the nucleosome and is the site of a huge diversity of post-translational modifications that support the maintenance of an active or inactive transcriptional state. Numerous modifications of histone H3 are known, including methylation or acetylation of arginine or lysine residues, and phosphorylation of serine or threonine residues; these modifications may promote or inhibit transcription.

Novus has recently launched a new monoclonal antibody against Histone H3 that is ChIP validated as well as WB and IHC-P.

Histone H3 (1B1-B2)...

PPAR gamma regulates adipocyte differentiation and binds peroxisome proliferators that include hypolipidemic drugs and fatty acids. It is found in the nucleus and the cytoplasm and is most prevalent in adipose tissue. PPAR gamma has been linked to many diseases such as obesity, diabetes, atherosclerosis, and cancer.

Novus has recently launched a new PPAR gamma antibody, Cat #NBP2-22106, that is validated for use in WB and IHC-P. It is available in 0.1ml and a 25ul trial size, as well as a...

Cell Cycle Checkpoints and Cancer

P2Y2, also known as P2Y purinoceptor 2, belongs to the G-protein coupled receptor family. This family has several receptor subtypes with different pharmacological selectivity, which overlaps in some cases, for various adenosine and uridine nucleotides. P2Y2 is responsive to both adenosine and uridine nucleotides and therefore acts as a receptor for both ATP and UTP. As result, P2Y2 plays a role in the activation of the phosphatidylinositol-calcium second messenger system. P2Y2 may also participate in control of...

New Factor VIII Antibody

Factor VIII is an essential blood clotting protein.  Upon injury, thrombin catalyzes factor VIII into an active form (factor VIIIa), which then associates with factor IXa.  This complex converts factor X into factor Xa, resulting in the amplification phase of coagulation.

Novus has recently launched a new Factor VIII antibody, catalog number...

New Product Offering: MUC1 Antibody

Mucin 1, or Muc1, is a large cell surface mucin glycoprotein involved with cell adhesion and tumor progression.  Mucins line the epithelial cells of many organs and protect them from pathogen infection.  Muc1 is often overexpressed certain cancers, including colon, breast, lung, ovarian, and pancreatic.

Novus now offers another Muc1 antibody, catalog number NB120-22711 which is...

Pages